Showing related tags and posts accross the entire site.
-
The Playbook 100 CELG @ $57.68 (Celgene) develops therapies to treat cancer and immune-inflammatory related diseases. Revenues have increased between 43% and 76% during each of the last four quarters. Earnings have increased between 72% and 136% during the same time frame and are expected to grow 43...
-
The Playbook 100 BRKR @ $15.42 (Bruker Corp) develops life science tools based on mass Spectrometry and materials research tools based on X-Ray technology. Revenues have accelerated 16%, 21%, 26% and 35% over the last four quarters. Earnings are expected to grow 74% this year and another 31% in 2009...
-
Momentum Stocks NUS @ $19.55 (Nu Skin Enterprise) is a network marketer of personal care products and nutritional supplements under the Nu Skin and Pharmanex brands. Earnings are expected to grow 38% this year and another 13% in 2009 to $1.36 a share. Institutional sponsorship has steadily increased...